(NASDAQ: AHCO) Adapthealth's forecast annual revenue growth rate of 4.28% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.68%.
Adapthealth's revenue in 2025 is $3,246,360,000.On average, 4 Wall Street analysts forecast AHCO's revenue for 2025 to be $439,151,372,923, with the lowest AHCO revenue forecast at $438,155,592,362, and the highest AHCO revenue forecast at $440,200,053,062. On average, 4 Wall Street analysts forecast AHCO's revenue for 2026 to be $460,656,535,479, with the lowest AHCO revenue forecast at $454,110,482,697, and the highest AHCO revenue forecast at $470,833,226,589.
In 2027, AHCO is forecast to generate $508,497,185,758 in revenue, with the lowest revenue forecast at $508,497,185,758 and the highest revenue forecast at $508,497,185,758.